16053-39-7,MFCD00083787
Catalog No.:AA00ACGD

16053-39-7 | H-Phe-ser-oh

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
≥ 95.5% (HPLC)
in stock  
$152.00   $107.00
- +
1g
≥ 95.5% (HPLC)
in stock  
$294.00   $206.00
- +
5g
≥ 95.5% (HPLC)
in stock  
$1,138.00   $797.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00ACGD
Chemical Name:
H-Phe-ser-oh
CAS Number:
16053-39-7
Molecular Formula:
C12H16N2O4
Molecular Weight:
252.2664
MDL Number:
MFCD00083787
SMILES:
OC[C@@H](C(=O)O)NC(=O)[C@H](Cc1ccccc1)N
Properties
Computed Properties
 
Complexity:
290  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
4  
Isotope Atom Count:
0  
Rotatable Bond Count:
6  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
-3.7  

Downstream Synthesis Route

[1]OrganicLetters,2006,vol.8,p.2417-2420

Literature

Title: Affinity and translocation relationships via hPEPT1 of H-X aa-Ser-OH dipeptides: evaluation of H-Phe-Ser-OH as a pro-moiety for ibuprofen and benzoic acid prodrugs.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20110201

Title: L-Isoleucyl-L-serine 0.33-hydrate, L-phenylalanyl-L-serine and L-methionyl-L-serine 0.34-hydrate.

Journal: Acta crystallographica. Section C, Crystal structure communications 20060101

Title: Concentration-dependent atypical intestinal absorption of cyclic phenylalanylserine: small intestine acts as an interface between the body and ingested compounds.

Journal: Biological & pharmaceutical bulletin 20031101

Title: Concentration-dependent preferences of absorptive and excretive transport cause atypical intestinal absorption of cyclic phenylalanylserine: small intestine acts as an interface between the body and ingested compounds.

Journal: Research communications in molecular pathology and pharmacology 20020101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:16053-39-7 Molecular Formula|16053-39-7 MDL|16053-39-7 SMILES|16053-39-7 H-Phe-ser-oh
Catalog No.: AA00ACGD
16053-39-7,MFCD00083787
16053-39-7 | H-Phe-ser-oh
Pack Size: 250mg
Purity: ≥ 95.5% (HPLC)
in stock
$152.00 $107.00
Pack Size: 1g
Purity: ≥ 95.5% (HPLC)
in stock
$294.00 $206.00
Pack Size: 5g
Purity: ≥ 95.5% (HPLC)
in stock
$1,138.00 $797.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00ACGD
Chemical Name: H-Phe-ser-oh
CAS Number: 16053-39-7
Molecular Formula: C12H16N2O4
Molecular Weight: 252.2664
MDL Number: MFCD00083787
SMILES: OC[C@@H](C(=O)O)NC(=O)[C@H](Cc1ccccc1)N
Properties
Complexity: 290  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 2  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 18  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 4  
Isotope Atom Count: 0  
Rotatable Bond Count: 6  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: -3.7  
Downstream Synthesis Route
13734-34-4    111061-56-4    16053-39-7 

[1]OrganicLetters,2006,vol.8,p.2417-2420

Literature fold

Title: Affinity and translocation relationships via hPEPT1 of H-X aa-Ser-OH dipeptides: evaluation of H-Phe-Ser-OH as a pro-moiety for ibuprofen and benzoic acid prodrugs.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V20110201

Title: L-Isoleucyl-L-serine 0.33-hydrate, L-phenylalanyl-L-serine and L-methionyl-L-serine 0.34-hydrate.

Journal: Acta crystallographica. Section C, Crystal structure communications20060101

Title: Concentration-dependent atypical intestinal absorption of cyclic phenylalanylserine: small intestine acts as an interface between the body and ingested compounds.

Journal: Biological & pharmaceutical bulletin20031101

Title: Concentration-dependent preferences of absorptive and excretive transport cause atypical intestinal absorption of cyclic phenylalanylserine: small intestine acts as an interface between the body and ingested compounds.

Journal: Research communications in molecular pathology and pharmacology20020101

Building Blocks More >
1960-52-7
1960-52-7
2-Methyl-4-nitrobenzotrifluoride
AA00ACTI | MFCD11226539
19156-52-6
19156-52-6
4,5-Dimethylthiophene-3-carboxylic acid
AA00ACZH | MFCD01859967
16337-02-3
16337-02-3
(3R,6R)-3,6-Bis[(aminooxy)methyl]-2,5-piperazinedione
AA00AD6I | MFCD16038770
168627-33-6
168627-33-6
N-Cyclopropylguanidine compound with sulfuric acid (2:1)
AA00ACYB | MFCD05022503
14382-79-7
14382-79-7
(3β,16E,20β)-16,17-Didehydro-9,17-dimethoxycorynan-16-carboxylic acid methyl ester
AA00ADJC
17614-10-7
17614-10-7
(1-Methylethyl)carbaMic Acid Phenyl Ester
AA00ADSH | MFCD00276276
15569-99-0
15569-99-0
4-(METHYLAMINO)-4-(3-PYRIDYL)BUTYRIC ACID
AA00AE01 | MFCD03412512
151889-03-1
151889-03-1
2-PHENYLMELATONIN
AA00AE8V | MFCD00673896
14038-43-8
14038-43-8
Iron(III) hexacyanoferrate(II)
AA00AI8A | MFCD00135663
1672-63-5
1672-63-5
4-Hydroxyantipyrine
AA00AK7C | MFCD00003143
Submit
© 2017 AA BLOCKS, INC. All rights reserved.